Akcea and Ionis Announce Initiation of CARDIO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with TTR-mediated Amyloid Cardiomyopathy

    NEXT STORY
    Global In-Vitro Diagnostics (IVD) Market Report, 2019-2025 – Advent of NGS has Created a Significant Opportunity for Advances in IVD Tests
    PREV STORY
    Press release Oncology Venture issues 287,500 new shares in connection with a debt conversion
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Philips makes access to care and personalized telehealth for local communities real with Virtual Care Station

    author_avatar
    NASDAQ Market News

    Emergent BioSolutions Reports Financial Results for First Quarter 2020

    author_avatar
    NASDAQ Market News

    Neon Therapeutics Announces Updated Data Presented at Society for Immunotherapy of Cancer (SITC) Annual Meeting

    author_avatar
    NASDAQ Market News